(EPA)

Antimicrobial resistance: Concerning data from Cyprus and Greece

Add your Headline Text Here
@fyinews team

19/11/2026

Copy link
fyi:
  1. Cyprus records the highest rate of bloodstream infections caused by Klebsiella pneumoniae resistant to carbapenems, a class of powerful antibiotics, according to a new ECDC report.
  2. The rate in Cyprus stands at 21.29 cases per 100,000 people, nearly six times the EU average of 3.75. Greece also records a high rate, at 16.28 cases per 100,000 people.
  3. The ECDC warns that the spread of antibiotic-resistant bacteria is making infections harder to treat by limiting available treatment options.

 

News


Antimicrobial resistance remains a serious concern across Europe, with Cyprus recording the highest rate of bloodstream infections caused by resistant Klebsiella pneumoniae in the European Union and Greece also reporting particularly high rates, according to new figures published yesterday by the European Centre for Disease Prevention and Control (ECDC).

In Cyprus, the estimated incidence of bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae reached 21.29 cases per 100,000 people in 2025, nearly six times the EU average of 3.75. In Greece, the corresponding rate stood at 16.28 cases per 100,000, more than four times the EU average and up from 14.89 in 2024.

High rates were also recorded for other resistant bacteria. In Cyprus, the incidence of bloodstream infections caused by Escherichia coli resistant to third-generation cephalosporins reached 23.30 cases per 100,000 people, compared with 12.13 across the EU and 6.57 in Greece. However, the rate in Greece has risen by 154.7% since 2019.

The ECDC stresses that tackling antimicrobial resistance requires more than reducing antibiotic consumption.

For methicillin-resistant Staphylococcus aureus (MRSA), the incidence stood at 12.07 cases per 100,000 people in Cyprus and 5.48 in Greece, compared with an EU average of 4.56. Across the EU, bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae increased by 72% between 2019 and 2025, despite a target to reduce their incidence by 5% by 2030.

On the occasion of European Antibiotic Awareness Day, the ECDC warned that the spread of resistant bacteria is progressively limiting treatment options and requires coordinated action across healthcare systems.

The agency emphasised that tackling antimicrobial resistance goes beyond reducing antibiotic consumption. It also requires robust surveillance systems, effective infection prevention and control measures, particularly in hospitals, and the early detection of resistant microorganisms.

Sources: ECDC (1, 2), Phileleftheros

 

AD(1024x768)